Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.4 EUR | 0.00% | -4.00% | -21.31% |
Apr. 29 | Siav S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 03 | ITALY GROWTH WINNERS & LOSERS: Health Italia and Askoll EVA leading the way. | AN |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 51% by 2026.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company has a low valuation given the cash flows generated by its activity.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-21.31% | 23.24M | - | ||
+12.51% | 3,096B | C+ | ||
+12.68% | 85.37B | B | ||
+7.61% | 77.1B | B+ | ||
-13.71% | 54.31B | B+ | ||
-22.56% | 47.92B | B- | ||
+26.21% | 47.74B | D+ | ||
+25.42% | 42.15B | D+ | ||
+69.48% | 38.06B | D+ | ||
-8.00% | 24.73B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SIAV Stock
- Ratings Siav S.p.A.